Global Women’s Health Market Value Projected to Expand by 2019-2026

The global women’s health market size was valued at USD 36.5 billion in 2016 and is expected to reach USD 51.3 billion by 2025, with a CAGR of 3.9%.

Women’s health needs to be understood in the perspective of their psychological and cultural environment.In 1900, a woman’s lifespan was about 50 years but now in the new millennium, average life expectancy for American women is 82 years of age, and it is continuing to rise.

Gynecology is the primary branch of medical science concerned with women’s health issues.

The National Institutes of Health (NIH) established Women’s Health Initiative (WHI) in 1991 to address the most common causes of death, disability, and impaired quality of life in postmenopausal women.

The Agency of Healthcare Research and Quality (AHRQ) supports research on all aspects of healthcare provided to women.Request a Free Sample Copy of Women’s Health Market Report @ https://www.millioninsights.com/industry-reports/womens-health-market/request-sampleWith many countries pitching for improving the healthcare facilities for women, the market for women’s health will have a positive viewpoint in the years to come.

The U.S. government spent 17% of their GDP on the healthcare sector in 2014.Women’s Health Market is segmented on the basis of application and analysis, drug class, and region.

A new research study from “Data Bridge Market Research”  with title Women’s Health Market Insights 2019, Global  Analysis and Forecast to 2026 provides an in-depth assessment of the Women’s Health including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies.

Key players profiled in this report are: Eli Lilly and Company; Novartis AG; Pfizer Inc.; Merck & Co., Inc.; Novo Nordisk A/S; Amgen Inc.; Lupin Pharmaceuticals, Inc.; AstraZeneca; F. Hoffmann-La Roche Ltd; Sanofi; Johnson & Johnson Services, Inc.; GlaxoSmithKline plc; Bayer AG; Theramex; Agile Therapeutics; Blairex Laboratories, Inc.; Bristol-Myers Squibb Company; Ferring B.V.; Abbott; Enteris BioPharma; Evestra, Inc.; Gedeon Richter; HRA Pharma; JDS Therapeutics, LLC; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Radius HealthGlobal women’s health market is expected to register a steady CAGR of 4.96% in the forecast period of 2019-2026.

The report contains data from the base year of 2018 and the historic year of 2017.A sample of this report is available upon request @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-womens-health-marketSegmentation: Global Women’s Health MarketGlobal Women’s Health Market By Product Type (Devices, Drugs, Pharmaceutical Pipeline)Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Surgeries)Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, Others)Disease Indication (Cancer, Reproductive Health, Hypothyroidism, Post-Menopausal Syndrome, Urological Disorders, Others)End-Users (Hospitals & Clinics, Gynecology Centers, Research Institutes, Others)Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026Key Developments in the Market:In June 2019, AbbVie Inc. announced that they had agreed with ALLERGAN to acquire the assets available with ALLERGAN for approximately USD 63 billion.

This acquisition is a strategic step for the organizations as the combined capabilities will provide vast areas of applications for the pharmaceuticals organizations as well as driving the innovations in the applicable market.

This acquisition will also provide cash injection into the operations which will provide more areas for revenue generation.In February 2018, CVC VI announced that they had formulated a new company known as Theramex that will deal with providing products, therapeutics to the women population for treatment of contraceptives, fertility, menopause and osteoporosis.

The company will be situated in London, England.

The Global Women’s Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.

The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.DriversRising occurrences of chronic and lifestyle-related disorders in womenFavorable government policiesRestraintsHigh cost of diagnostic proceduresThe comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.

The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on application.

These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.

The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Browse the complete Global Women’s Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/21027-womens-health-market-reportThe report also covers the complete competitive landscape of the global Women’s Health market with company profiles of key players such as:Agile TherapeuticsAllergan, Inc.Amgen, Inc.Apothecus Pharmaceutical CorporationAstraZenecaBayer AGBlairex Laboratories, Inc.Bristol-Myers Squibb CompanyFerring B.V.Merck & Co., Inc.Pfizer, Inc.Teva Pharmaceutical Industries Ltd.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Applications:Postmenopausal OsteoporosisInfertilityEndometriosisContraceptivesMenopausePolycystic Ovary Syndrome (PCOS)By Geography:North America (NA) – US, Canada & Rest of North AmericaEurope (EU) – UK, Germany, France & Rest of EuropeAsia Pacific (APAC) – China, Japan, India & Rest of APACLatin America (LA) – Brazil & Rest of Latin AmericaMiddle East & Africa (MEA) – Middle East and AfricaDownload Free Sample Report of Global Women’s Health Market @ https://www.decisiondatabases.com/contact/download-sample-21027The Global Women’s Health Market has been exhibited in detail in the following chapters -Chapter 1 Women’s Health Market PrefaceChapter 2 Executive SummaryChapter 3 Women’s Health Industry AnalysisChapter 4 Women’s Health Market Value Chain AnalysisChapter 5 Women’s Health Market Analysis By ApplicationsChapter 6 Women’s Health Market Analysis By GeographyChapter 7 Competitive Landscape Of Women’s Health CompaniesChapter 8 Company Profiles Of Women’s Health IndustryPurchase the complete Global Women’s Health Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-21027Other Reports by DecisionDatabases.com:Global Digital Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Health Ingredients Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global M-Health Applications Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.

Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/womens-health-market/request-sample The key driving factors responsible for the growth of Women’s Health market : In 1900, a woman’s lifespan was about 50 years but now in the new millennium, average life expectancy for American women is 82 years of age, and it is continuing to rise.

Gynecology is the primary branch of medical science concerned with women’s health issues.

The National Institutes of Health (NIH) established Women’s Health Initiative (WHI) in 1991 to address the most common causes of death, disability, and impaired quality of life in postmenopausal women.

The Agency of Healthcare Research and Quality (AHRQ) supports research on all aspects of healthcare provided to women.

With many countries pitching for improving the healthcare facilities for women, the market for women’s health will have a positive viewpoint in the years to come.

The U.S. government spent 17% of their GDP on the healthcare sector in 2014.

19 February 2020 - The global Women’s Health Market size was valued at USD 36.5 billion in 2016 and is expected to reach USD 51.3 billion by 2025, with a CAGR of 3.9%.

The general practice management of women’s health involves a general patient-centered approach toward the physical, mental, and emotional health of women, their families, and their relationships.

Women’s health needs to be understood in the perspective of their psychological and cultural environment.In 1900, a woman’s lifespan was about 50 years but now in the new millennium, average life expectancy for American women is 82 years of age, and it is continuing to rise.

Gynecology is the primary branch of medical science concerned with women’s health issues.

The National Institutes of Health (NIH) established Women’s Health Initiative (WHI) in 1991 to address the most common causes of death, disability, and impaired quality of life in postmenopausal women.

The Agency of Healthcare Research and Quality (AHRQ) supports research on all aspects of healthcare provided to women.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/womens-health-marketWith many countries pitching for improving the healthcare facilities for women, the market for women’s health will have a positive viewpoint in the years to come.

In this day and time, important and focus on women and their health has increased significantly.

Governments of various countries are also making substantial efforts in improving and providing better health facilities to women.

Moreover, increasing different types of diseases among women cancer of different parts such as breast, ovaries, and cervical and other disease including UTI, post-menopausal syndrome, hypothyroidism, contraceptive, and osteoporosis has highlighted the need for better and advanced healthcare facilities for women.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=214 With growing need for better and improved healthcare facilities for women, Transparency Market Research has published a report on the global women’s health market.

The market growing at a healthy rate and with increased focus on providing better health care facilities to the women, opportunities for the stakeholders in this market are estimated to be high and lucrative.Increasing Initiatives Taken by Players in Getting New FDA Approval for New Indication to Benefit Women’s Health MarketWitnessing high growth opportunities in the global women’s health market, players in this market are making constant efforts to increase their revenue share by increasing their presence in different regions.

Leading players are engaged in establishing relationship with companies already existing in specific region through investing in mergers and acquisition, collaboration, partnership, and expansion.

For example, Prolia is given  to women during postmenopausal as women are vulnerable to bone fractures because of osteoporosis.